The landscape of microbiota research in Iran; a bibliometric and network analysis
- 6 Downloads
To introduce bibliometric features of Iranian documents on microbiota and to provide descriptive information about retrieved documents related to the medical sciences and documents utilizing molecular techniques for microbiota detection.
This is a descriptive bibliometric study of all Iranian documents on microbiota in any language that were indexed in Scopus before 7 September 2019. We assessed the research performance through statistical analysis of the bibliometric indicators, including number of publications, citations, institutions and journals activities, co-citations and bibliographic couplings, and network analysis of co-authorships, countries’ collaborations, terms and keywords.
We extracted 425 relevant documents, 260 of which pertain to the medical sciences. The most focused microbiota modulating interventions and diseases in 33 clinical trials are ‘synbiotics’ (n = 8) and ‘probiotics’ (n = 8), and ‘Obesity’ (n = 3) and ‘non-alcoholic fatty liver disease’ (n = 3), respectively. During the last decade, Iranian microbiota publications have increasingly grown with a constant upward slope, particularly in the area of medical sciences after 2016. Citation counting reveals that originals and reviews have been cited 4221 times, with an average 10.76 citations and H-index of 34. The most significant performance in publishing Iranian microbiota documents belongs to ‘Tehran University of Medical Sciences’ as the active institution (n = 89 publications) and the supporting sponsor (n = 19), ‘Microbial Pathogenesis’ as the productive journal (n = 12), ‘Seidavi A’ as the most authorships (n = 19), and ‘the United States’ as the collaborative country (n = 46).
The qualitative and quantitative information of this study will be a practical guidance for future study planning and policy-decision making.
KeywordsMicrobiota Microbiome Scientometrics Bibliometrics Iran
H.A., H.D., H.E., F.R. and P.P. conceived of the presented idea. S.D.S., B.L. and P.P. developed the theory and H.A. performed the computations. N.F., A.S., S.A.B, and S.H.R. verified the analytical methods. H.E. investigated the molecular technique aspect of retrieved articles, H.E., H.A., and H.D. contributed to the interpretation of the results and S.D.S supervised the findings of this work. H.D. and H.A. wrote the manuscript in consultation with H.E. and N.F. All authors discussed the results, provided critical feedback, helped shape the research and analysis, and contributed to the final manuscript.
This study was funded by the Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
Consent for publication
Ethics approval and consent to participate
- 2.Sharifi V, Rahimi Movaghar A, Mohammadi M, Goodarzi R, Izadian E, Farhoudian A et al. Analysis of mental health research in the Islamic Republic of Iran over 3 decades: a scientometric study. 2008.Google Scholar
- 7.Pritchard A. Statistical bibliography or bibliometrics. J Doc. 1969;25(4):348–9.Google Scholar
- 9.Baudoin L, Sapinho D, Maddi A, Miotti L. Scientometric analysis of the term “microbiota” in research publications (1999-2017): A second youth of a century-old concept. FEMS Microbiol Lett. 2019;366(12).Google Scholar
- 10.The unseen life of the soil. Science. 1927;65(1695):x–x. https://doi.org/10.1126/science.65.1695.0x.
- 16.Mraz O, Cerny L, editors. Functional Composition+ Main Metabolites of Rumen Microflora in Cattle with Definite Food Intake. FOLIA MICROBIOLOGICA; 1964: INST MICROBIOLOGY, VIDENSKA 1083, PRAGUE 4 142 20, CZECH REPUBLIC.Google Scholar
- 25.Team S. Science of science (Sci2) tool. Indiana University and SciTech Strategies. 2009.Google Scholar
- 26.Nazemi M, Amini M, Salehi R. Difference in quantities of bifidobacteria from the intestinal microflora of individuals with type 2 diabetes and healthy individuals from Iran. Journal of Isfahan Medical School. 2013;31(247):1216–1225.Google Scholar
- 28.Heidarian F, Noormohammadi Z, Aghdaei HA, Alebouyeh M. Relative abundance of streptococcus spp. and its association with disease activity in inflammatory bowel disease patients compared with controls. Arch Clin Infect Dis. 2017;12(2) e57291.Google Scholar
- 35.Rezasoltani S, Sharafkhah M, Aghdaei HA, Mojarad EN, Dabiri H, Sepahi AA, et al. Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer. J Microbiol Methods. 2018;155:82–8.CrossRefGoogle Scholar
- 36.Al-Bayati L, Fasaei BN, Merat S, Bahonar A. Longitudinal analyses of gut-associated bacterial microbiota in ulcerative colitis patients. Arch Iran Med (AIM). 2018;21(12).Google Scholar
- 37.Tavasoli S, Alebouyeh M, Naji M, Shakiba majd G, Shabani Nashtaei M, Broumandnia N, et al. The association of the intestinal oxalate degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study. BJU Int. 2019;125(1):133–143.Google Scholar
- 38.Mohammadzadeh N, Kalani BS, Bolori S, Azadegan A, Gholami A, Mohammadzadeh R, et al. Identification of an intestinal microbiota signature associated with hospitalized patients with diarrhea. Acta Microbiol Immunol Hung. 2019:1–14.Google Scholar
- 42.Mousavi SH, Mehrara S, Barzegari A, Ostadrahimi A. Correlation of gut microbiota profile with body mass index among school age children. Iran Red Crescent Med J. 2018;20(4):e58049 (In Press).Google Scholar
- 43.Ejtahed H-S, Tito RY, Siadat S-D, Hasani-Ranjbar S, Hoseini-Tavassol Z, Rymenans L, et al. Metformin induces weight loss associated with gut microbiota alteration in non-diabetic obese women: a randomized double-blind clinical trial. Eur J Endocrinol. 2018;180(3):165–176(aop).Google Scholar
- 44.Payahoo L, Khajebishak Y, Alivand MR, Soleimanzade H, Alipour S, Barzegari A, et al. Investigation the effect of oleoylethanolamide supplementation on the abundance of Akkermansia muciniphila bacterium and the dietary intakes in people with obesity: a randomized clinical trial. Appetite. 2019;141:104301.CrossRefGoogle Scholar
- 45.Laffin MR, Tayebi Khosroshahi H, Park H, Laffin LJ, Madsen K, Kafil HS, et al. Amylose resistant starch (HAM-RS2) supplementation increases the proportion of Faecalibacterium bacteria in end-stage renal disease patients: microbial analysis from a randomized placebo-controlled trial. Hemodial Int. 2019;23(3):343–347.Google Scholar
- 47.Hosseinifard E-S, Morshedi M, Bavafa-Valenlia K, Saghafi-Asl M. The novel insight into anti-inflammatory and anxiolytic effects of psychobiotics in diabetic rats: possible link between gut microbiota and brain regions. Eur J Nutr. 2019;58(01):1–15.Google Scholar
- 49.Seidavi A, Mirhosseini SZ, Shivazad M, Chamani M, Sadeghi AA. The development and evaluation of a duplex polymerase chain reaction detection of Bifidobacterium spp. and Lactobacillus spp. in duodenum, jejunum, ileum and cecum of broilers. J Rapid Meth Aut Microbiol. 2008;16(1):100–12.CrossRefGoogle Scholar
- 62.Cho YA, Kim J. Effect of probiotics on blood lipid concentrations: a meta-analysis of randomized controlled trials. Medicine. 2015;94(43) e1714.Google Scholar
- 64.Mahmoudi R, Fakhri O, Farhoodi A, Kaboudari A, Rahimi SF. A review on probiotic dairy products as functional foods reported from Iran. Int J Food Nutr Saf. 2015;6(1):2.Google Scholar
- 67.Ejtahed H-S, Soroush A-R, Siadat S-D, Hoseini-Tavassol Z, Larijani B, Hasani-Ranjbar S. Targeting obesity management through gut microbiota modulation by herbal products: a systematic review. Complement Ther Med. 2018;42:184–204.Google Scholar